MUC4 expression was then determined by RT-PCR and/or Western blotting. Results: DEPs significantly increased the expression of MUC4 mRNA and protein. MUC4 mRNA and protein expression was inhibited by pretreatment with p38 and CREB inhibitors in NCI-H292 stimulated with DEPs. p38 and CREB inhibitors also blocked the expression of MUC4 mRNA and protein in DEP-stimulated PNECs. Conclusions: We demonstrated that DEPs stimulated the expression of MUC4 via the p38/CREB pathway in NCI-H292 cells and PNECs. The results of the present study pave the way for further studies on the role of MUC4 in DEP-induced hypersecretion in airway epithelium.
with the help of ciliary movements [2] . The most important components of the airway mucus are water and mucins. Mucins are heavily glycosylated glycoproteins with variable numbers of tandem repeats of certain amino-acid sequences that are rich in serine, threonine, and proline. At least 22 mucin genes have been cloned from humans. There are two kinds of mucin gene products. One is characterized as secreted and the others are membrane tethered. Transmembrane mucins are mostly expressed on the apical side of mucosal epithelium and are supposed to have a defensive role for the host [3] . MUC4 is a member of the transmembrane mucin family, and it is expressed in airway epithelial cells. Abnormal expression of MUC4 has been reported in various inflammatory diseases and cancers [4] .
Exhaust fumes from diesel engines are the dominant source of atmospheric contamination [5] . Incomplete combustion of diesel fuels produces a complex mixture of gaseous and diesel exhaust particles (DEPs), which affect urban air quality and human respiratory health [6] . In epidemiological studies, it has been reported that the rates of respiratory disease morbidity are high in populations exposed to DEPs [7, 8] . Many researchers have explored the mechanisms by which DEPs induce respiratory disease. The most well-known findings have revealed the proinflammatory effects of DEPs on the airways [9] . The relationship between DEPs and mucus secretion is another focus. In a study on human middle ear epithelial cells, exposure to DEPs increased the expression of MUC5AC, a secreted form of mucin [10] . Goblet cell hyperplasia of the nasal mucosa was also observed in a group of officers occupied with clearing diesel vehicles over 5 years [11] .
Based on the above findings, we hypothesized that DEPs can also affect the expression of transmembrane mucins such as MUC4 in the respiratory epithelium. In the present study, we investigated whether DEPs could stimulate MUC4 mucin production in primary nasal epithelial cells (PNECs) and identified the downstream pathways such as the mitogen-activated protein kinase (MAPK) pathway, which is known to be triggered following exposure of human respiratory epithelial cell lines to DEPs.
Materials and Methods
Reagents DEPs (SRM 2975; National Institute of Standards and Technology, Gaithersburg, MD, USA) used in this study were suspended in sterile saline (NaCl 0.9%) containing Tween 80 (0.01%). To minimize aggregation, particle suspensions were sonicated for 15 min and vortexed prior to use. Inhibitors of extracellular signal-regulated kinase (ERK) (U0126), p38 (SB203580), c-Jun N-terminal kinase (JNK) (SP600125), and CREB (cAMP response element-binding protein) (CAS 92-78-4) were purchased from Calbiochem (Billerica, MA, USA). MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, was obtained from Sigma (St. Louis, MO, USA). Antibodies against MUC4, phosphorylated (p)-p38, totalp38, and β-actin were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). p-CREB and total-CREB antibodies were obtained from Cell Signaling Technology (Danvers, MA, USA).
Cell Culture NCI-H292 (human lung mucoepidermoid carcinoma cell line) cells were obtained from the American Type Culture Collection (Manassas, VA, USA). NCI-H292 cells were cultured in RPMI 1640 medium containing 10% (v/v) heat-inactivated fetal bovine serum (Invitrogen, Carlsbad, CA, USA), 1,000 unit/mL penicillin, and 1,000 μg/mL streptomycin (Invitrogen).
Inferior turbinate mucosal specimens were obtained from 5 patients during endoscopic sinus surgery for benign tumors at the Department of Otorhinolaryngology at the Korea University Guro Hospital. None of the patients had a history of allergies, asthma, or aspirin sensitivity, and neither of them received steroids, nonsteroidal anti-inflammatory drugs, antihistamines, or antibiotics during the 4 weeks prior to the biopsy. Epithelial cells were detached from the human nasal tissue by dispase II (1 U/mL) (StemCell Technologies, Vancouver, BC, Canada), followed by filtration and centrifugation. The cells were suspended in BEBM (bronchial epithelial cell basal medium) supplemented with 2 mL bovine pituitary extract, 0.5 mL insulin, 1,027 M hydrocortisone, 0.5 mL retinoic acid, 0.5 mL transferrin, 0.5 mL epinephrine, 0.5 mL human epidermal growth factor (Lonza, Basel, Switzerland), and retinoic acid (1 μg/mL). The cells were maintained at 37 ° C in 5% CO 2 and 95% air, and were allowed to adhere to the culture plate for 3 days. The study was approved by the Institutional Review Board of the Korea University Guro Hospital (KUGH12041-001). 
MTT Assay
To determine the cytotoxic effects of DEP in NCI-H292 cells, the MTT assay was used. Cells (1 × 10 4 cells/well in 96-well plates) were incubated with MTT for 4 h, and the reaction was terminated by the addition of dimethyl sulfoxide. A fluorescence microplate reader (F2000; Hitachi, Ltd., Tokyo, Japan) was used to determine the results (570 nm).
Immunofluorescent Staining of MUC4
NCI-H292 cells (5 × 10 4 cells/well in 24-well plates) were fixed with 4% paraformaldehyde. Cells were then permeabilized with 0.2% Triton X-100 in 1% bovine serum albumin for 10 min, blocked with 5% bovine serum albumin for 1 h at room temperature, and incubated overnight at 4 ° C with rabbit anti-human MUC4 antibody. The cells were then incubated with DyLight 488 horse anti-rabbit IgG antibody (Vector Laboratories, Burlingame, CA, USA). Finally, the cells were counterstained with 4 ′ ,6-diamidino-2-phenylindole (Invitrogen). The immunostained cells were captured and visualized using a confocal microscope (LSM700; Zeiss, Oberkochen, Germany).
Reverse Transcription Polymerase Chain Reaction
Total RNA (3 × 10 5 cells/well in 6-well plates) was isolated according to the manufacturer's recommendations using TRIzol reagent (Invitrogen). Reverse transcription (RT) was performed with 2 μg of RNA per sample. Total RNA was denatured at 65 ° C for 5 min and cooled on ice. Denatured total RNA was added to 10 μL of 5× reverse transcriptase buffer, 5 μL of 2.5-m M dNTP mix, 1 μL of RNase inhibitor, and 1 μL of Moloney murine leukemia virus reverse transcriptase for cDNA synthesis. Real-time polymerase chain reactions (PCRs) were then performed in a 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) using 3 mL of cDNA template, 1 nmol of primers, and 12.5 mL of Power SYBR Green PCR Master Mix (Applied Biosystems) in a total reaction volume of 25 mL. PCR was performed using the following primers for MUC4 (sense sequence, 5 ′ -GACTTGGA-GCTCTTTGAGAATGG-3 ′ ; anti-sense sequence, 5 ′ -TGCAATG-GCAGACCACAGTCC-3 ′ ; 138 bp) and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (sense sequence, 5 ′ -GCAAATT-CCATGGCACCGT-3 ′ ; anti-sense sequence, 5 ′ -TCGCCCCAC-TTGATTTTG1G-3 ′ ; 106 bp). Amplification reactions were per- 212 formed as follows: an initial denaturation step at 94 ° C for 10 min, followed by 50 cycles at 95 ° C for 10 s, 58 ° C for 10 s, and 72 ° C for 10 s; a melting curve was generated. All reactions were performed in a 20-mL volume. To confirm the amplification specificity, the PCR products obtained from each primer pair were subjected to melting curve analysis. Analysis of relative gene expression was performed by evaluating the quantitative RT-PCR data using the 2 -ΔΔC t method. The gene expression levels were normalized to that of GAPDH.
Western Blot Analysis Cells (6 × 10
5 cells/60-mm dish) were lysed in PRO-PREP TM protein extraction solution (iNtRON Biotechnology, Seongnam, Korea). Lysates were separated by 10% SDS-PAGE and transferred onto polyvinyl difluoride membranes (Millipore Inc., Billerica, MA, USA). The membranes were blocked with 5% skim milk solution and incubated with the following antibodies: MUC4, p-p38, total-p38, p-CREB, total-CREB, and β-actin. The blots were visualized with HRP-conjugated secondary antibodies and an ECL system (Pierce, Rockford, IL, USA).
Statistical Analysis
Results were obtained from at least 3 independent experiments. The statistical significance of differences between the control and experimental data was analyzed with an unpaired t test or 1-way analysis of variance followed by Tukey's test (GraphPad Prism, version 5; GraphPad Software, San Diego, CA, USA). Significance was established at the 95% confidence level. p values less than 0.05 were accepted as statistically significant.
Results

DEPs Stimulate MUC4 Production in NCI-H292 Cells
We first examined the cytotoxic effect of DEPs on NCI-H292 cells using the MTT assay. DEPs did not show any cytotoxic effects after a 72-h exposure up to a concentration of 200 μg/ml ( Fig. 1 ) . We evaluated the ability of DEPs to stimulate MUC4 mRNA gene expression. Cells were treated with DEPs (25, 50, and 100 μg/ml), and the expression of MUC4 mRNA was determined by RT-PCR after 12 h. Treatment with DEPs significantly increased the expression of MUC4 mRNA in a dose-dependent manner ( Fig. 2 a) . We determined whether ( Fig. 2 b) . To confirm this finding, immunofluorescence staining of MUC4 protein was performed. Treatment with DEPs for 72 h was found to increase MUC4 protein levels ( Fig. 2 c) .
p38 Regulates the Production of MUC4 by DEPs in NCI-H292 Cells
To determine the effect of DEPs on intracellular signaling for MUC4 production in NCI-H292 cells, 3 MAPKs (p38, ERK 1/2, and JNK) were evaluated. NCI-H292 cells were pretreated with MAPK inhibitors (ERK inhibitor: U0126; p38 inhibitor: SB203580; and JNK inhibitor: SP600125) for 1 h and then treated with DEPs. After 12 h of treatment, the expression of MUC4 mRNA was significantly inhibited only by the p38 inhibitor ( Fig. 3 a) . The protein level of MUC4 determined after 72 h was also decreased by the p38 inhibitor ( Fig. 3 b) . We examined the activation of p38 signaling protein by DEPs using Western blot analysis. Cells treated with DEPs for 15 min showed increased phosphorylation of p38 ( Fig. 3 c) . 
CREB Regulates the Production of MUC4 by DEPs in NCI-H292 Cells
To explore the role of the CREB signaling pathway in the expression of MUC4 in DEP-stimulated NCI-H292 cells, cells were treated with DEPs with or without the CREB inhibitor (CAS 92-78-4). In NCI-H292 cells, MUC4 mRNA expression determined by RT-PCR was inhibited by the CREB inhibitor after 12 h of DEP treatment ( Fig. 4 a) . Western blot analysis results after 72 h of DEP treatment mirrored the RT-PCR results ( Fig. 4 b) . We also determined whether other activators of CREB such as forskolin can lead to MUC4 protein expression. In Western blot analysis, treatment of forskolin (40 μ M ) for 72 h increased the expression of MUC4 protein ( Fig. 4 c) . Using Western blotting, we confirmed that phosphorylation of CREB is inhibited not only by the CREB inhibitor but also by the p38 inhibitor ( Fig. 4 d) . These results indicate that DEPs induced the expression of MUC4 via the p38/CREB pathway in NCI-H292 cells.
DEPs Induce MUC4 Expression in PNECs via the p38/ CREB Pathway
We evaluated whether DEPs could also stimulate MUC4 gene and protein expression in PNECs. PNECs were pretreated with the p38 inhibitor or the CREB inhibitor for 1 h, and then stimulated with DEPs for 12 h (for RT-PCR) or 72 h (for Western blotting). Pretreatment with the p38 and CREB inhibitors prevented DEPinduced MUC4 mRNA and protein expression in PNECs ( Fig. 5 a, b) . In general, experiments with PNECs produced results similar to those obtained with NCI-H292 cells.
Discussion
The present study showed that MUC4 mRNA and protein expression was significantly increased by DEPs in NCI-H292 cells and PNECs. DEPs stimulated the expression of MUC4 mRNA and protein in a dose-dependent manner in NCI-H292 cells. When DEP-stimulated NCI-H292 cells were treated with specific inhibitors of p38, ERK, and JNK, only the p38 inhibitor reversed DEP-induced MUC4 production. The p38 inhibitor also inhibited DEP-induced MUC4 expression. DEPs increased p38 phosphorylation in NCI-H292 cells. A CREB inhibitor blocked the expression of MUC4 mRNA and protein in DEP-stimulated NCI-H292 cells as well as PNECs. CREB phosphorylation was inhibited not only by the CREB inhibitor, but also by the p38 inhibitor in both cells. Our results indicate that DEPs induce MUC4 mRNA and protein expression through the p38/CREB pathway in NCI-H292 cells and PNECs. 
